Tactile Systems Technology (TCMD) Reports 12% Revenue Growth to $329.5M for 2025

During this period, the institution acquired Lymphotec to people the ample colonisation of undiagnosed lymphedema patients. By integrating Lymphotec’s fluid-monitoring tech into its commercialized engine, Tactile aims to heighten diligent surveillance and streamline the way to therapy. The CEO noted that 2024 investments successful a caller CRM strategy and expanded income headcount are present driving productivity gains. Additionally, updated Medicare National Coverage Determination criteria person provided a tailwind by allowing definite patients to entree the FlexiTouch strategy much directly.

A aesculapian technician holding the instruments successful her hands

Despite the affirmative momentum, Tactile Systems Technology Inc. (NASDAQ:TCMD) issued a balanced outlook for 2026, projecting gross maturation of 8% to 11%. This guidance accounts for a imaginable short-term headwind: a caller Medicare anterior authorization request for pneumatic compression devices.

Tactile Systems Technology Inc. (NASDAQ:TCMD) is simply a aesculapian exertion institution that develops and provides aesculapian devices to dainty underserved chronic diseases successful the US.

While we admit the imaginable of TCMD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street.

Disclosure: None.